Skip to main content

One Health for Headache

Guest Editors:
Matilde Leonardi; Istituto Neurologico "Carlo Besta" - Fondazione IRCCS, Italy
Paolo Martelletti; Sapienza University of Rome, Italy

Submission Status: Open   |   Submission Deadline: 30 June 2024


BMC The Journal of Headache and Pain is calling for submissions to our Collection on One Health for Headache. This Collection aims to create a cross-disciplinary space for researchers, clinicians, academics, educators, patients’ organizations, and policy makers, working within and across clinical, social, and public health paradigms to address and reduce the burden of headache globally and reduce disability from this major non-communicable disease. We hope to bring together stakeholders who support the UN Sustainable Development Goals Agenda, in particular Sustainable Development Goal 3 (SDG3) of the 2030 Agenda for Sustainable Development that is “ensure healthy lives and promoting well-being for all at all ages” and the following associated targets: reduce mortality, and morbidity, from non-communicable diseases; strengthen the prevention and treatment of substance abuse and achieve universal health coverage.

Image Credit Springer Nature

Meet the Guest Editors

Back to top

Matilde Leonardi: Istituto Neurologico "Carlo Besta" - Fondazione IRCCS, Italy

Matilde Leonardi, MD, PhD, is a neurologist and paediatrician. She is Director of Neurology in the Public Health, Disability Unit and Coma Research Centre at Carlo Besta Neurological Institute in Milan, Italy. She is a Fellow of the European Academy of Neurology (EAN) and a World Health Organization (WHO) expert and consultant on neurology, disability, ageing, and policy development who is co-chair of the WHO NeuroCOVID Forum group on essential neurological services for COVID-19 recoverers. Leonardi is also a World Federation of Neurorehabilitation (WFNR) Presidium Member. Leonardi has more than 280 scientific publications on related topics and was awarded the Italian excellence for research in 2019.
 

Paolo Martelletti: Sapienza University of Rome, Italy

Paolo Martelletti, MD, PhD, is a Professor of Research at Sapienza University of Rome, Italy. His research activity involved over time headaches and pain neuroimmunology, chronicisation, and rehabilitation protocols, management guidelines, public health issues, and education in headache disorders, as well as COVID-19 and vaccines issues in medicine. He has edited several books in the headache field and is the Founding Editor-in-Chief of BMC Springer Nature The Journal of Headache and Pain, and Springer Nature Comprehensive Clinical Medicine.

About the Collection

Worldwide there is an urgent need to face the increasing burden of chronic non communicable conditions affecting global health, by providing affordable, feasible, and sustainable public health responses. Primary headaches represent one of the most relevant global public health problems, affecting a total of 52% of the world's population, with tension-type headache afflicting 26% of the population, migraine 14%, and headache present for more than fifteen days a month 4.6%. The Global Burden of Diseases 2019 indicated that this pathology is the most prevalent among non-communicable diseases when analyzing women under 50. Importantly, each day, 15.8% of the world's population had a headache. Furthermore, the long-term booster effect of COVID-19 on headaches burden has yet to be quantified. If we add to this the share of secondary headaches, the overall picture of these pathologies on the population becomes untenable requiring coordinated and structured interventions between stakeholders such as, academies, scientific and patient associations, publishers, drug companies inspired by the policies and recommendations of international organizations (UN, WHO).

The goal for this Collection is to create a cross-disciplinary space for researchers, clinicians, academics, educators, patients’ organizations, and policy makers, working within and across clinical, social, and public health paradigms to address and reduce the burden of headache globally and reduce disability from this major non communicable disease. We hope to bring together stakeholders who support the UN Sustainable Development Goals Agenda, in particular Sustainable Development Goal 3 (SDG3) of the 2030 Agenda for Sustainable Development that is “ensure healthy lives and promoting well-being for all at all ages” and the following associated targets: reduce mortality, and morbidity, from non-communicable diseases; strengthen the prevention and treatment of substance abuse and achieve universal health coverage.

Our aim is ambitious as we propose to the global community to rethink how to scale and implement actions using headache as a public health target to rethink policies towards SDG 3 by 2030.

We welcome scientific contributions reporting or discussing evidence-based strategies to:

- Reduce burden of primary headaches by reducing chronicity, barriers and impact on daily lives in a biopsychosocial perspective;

- Reduce medication overuse in acute management of primary headaches: strategies at primary, secondary, tertiary levels of care in a global perspective;

- Promote education of health care professionals in the management of primary headaches and define feasible methodology to support health-care facilities development to deliver comprehensive headache care pathways;

- Grant access to existing preventive and curative drugs for headaches in LMIC countries and facilitate the inclusion of these countries in research and development of new medicines (RCTs or RWS);

- Develop and implement training opportunities and education in low- and middle-income countries to improve the skills of health care professionals for management of headaches in primary and secondary care;

- Build a global alliance against headache disorders among headache lay and professional organizations as well as policy makers and relevant health and social authorities and stakeholders   to respond to public health needs in headache area.

  1. Current definitions of migraine that are based mainly on clinical characteristics do not account for other patient’s features such as those related to an impaired quality of life, due to loss of social life an...

    Authors: Claudio Tana, Bianca Raffaelli, Marcio Nattan Portes Souza, Elena Ruiz de la Torre, Daniel Gams Massi, Najib Kisani, David García-Azorín and Marta Waliszewska-Prosół
    Citation: The Journal of Headache and Pain 2024 25:12

    The Review to this article has been published in The Journal of Headache and Pain 2023 24:167

  2. The World Health Organization (WHO) Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders was developed by WHO to address the worldwide challenges and gaps in provision of care and serv...

    Authors: Matilde Leonardi, Paolo Martelletti, Rami Burstein, Arianna Fornari, Licia Grazzi, Alla Guekht, Richard B. Lipton, Dimos Dimitrios Mitsikostas, Jes Olesen, Mayowa Ojo Owolabi, Elena Ruiz De la Torre, Simona Sacco, Timothy J. Steiner, Nirmal Surya, Takao Takeshima, Cristina Tassorelli…
    Citation: The Journal of Headache and Pain 2024 25:4
  3. Headache disorders are a global public health concern affecting diverse populations. This review examines headache service organizations in low-, middle-, and high-income countries. It addresses global challen...

    Authors: Bianca Raffaelli, Eloísa Rubio-Beltrán, Soo-Jin Cho, Roberto De Icco, Alejandro Labastida-Ramirez, Dilara Onan, Raffaele Ornello, Ruth Ruscheweyh, Marta Waliszewska-Prosół, Roberta Messina and Francesca Puledda
    Citation: The Journal of Headache and Pain 2023 24:167

    The Review to this article has been published in The Journal of Headache and Pain 2024 25:12

  4. Migraine is a common disabling neurological disorder with severe physical and psychological damage, but there is a lack of convenient and effective non-invasive early prediction methods. This study aimed to de...

    Authors: Shaojie Duan, Hui Xia, Tao Zheng, Guanglu Li, Zhiying Ren, Wenyan Ding, Ziyao Wang and Zunjing Liu
    Citation: The Journal of Headache and Pain 2023 24:148
  5. Monoclonal antibodies (mAbs) targeting the Calcitonin Gene-Related Peptide (CGRP) pathway are safe and effective treatments for migraine prevention. However, the high cost of these novel therapies has led to r...

    Authors: Ja Bin Hong, Kristin Sophie Lange, Mira Fitzek, Lucas Hendrik Overeem, Paul Triller, Anke Siebert, Uwe Reuter and Bianca Raffaelli
    Citation: The Journal of Headache and Pain 2023 24:144
  6. The 2030 Agenda for Sustainable Development sets out, through 17 Sustainable Development Goals (SDGs), a path for the prosperity of people and the planet. SDG 3 in particular aims to ensure healthy lives and p...

    Authors: Paolo Martelletti, Matilde Leonardi, Messoud Ashina, Rami Burstein, Soo-Jin Cho, Augustina Charway-Felli, David W. Dodick, Raquel Gil-Gouveia, Licia Grazzi, Christian Lampl, Antoinette MaassenVanDenBrink, Mia T. Minen, Dimos Dimitrios Mitsikostas, Jes Olesen, Mayowa Ojo Owolabi, Uwe Reuter…
    Citation: The Journal of Headache and Pain 2023 24:140
  7. Headaches are the most common complaints among pediatric populations. Determining the cause and appropriate treatment for headaches may be challenging and costly, and the impact of headaches on the lives of pa...

    Authors: S. Ombashi, E. Tsangaris, A. G. Heeres, V. van Roey, R. F. Neuteboom, M. L. C. van Veelen-Vincent, K. Jansson, I. M. J. Mathijssen, A. F. Klassen and S. L. Versnel
    Citation: The Journal of Headache and Pain 2023 24:127
  8. In recent years, headache disorders have garnered significant attention as a pressing global health issue. This concern is especially pronounced in low- to middle-income countries and exhibits a notable increa...

    Authors: Xin-yu Li, Cheng-hao Yang, Jia-jie Lv, Hui Liu, Lu-yu Zhang, Min-yi Yin, Zhi-lin Guo and Ru-hong Zhang
    Citation: The Journal of Headache and Pain 2023 24:126

    The Correction to this article has been published in The Journal of Headache and Pain 2023 24:156

  9. There is a bidirectional link between sleep and migraine, however causality is difficult to determine. This study aimed to investigate this relationship using data collected from a smartphone application.

    Authors: Emily C. Stanyer, Jack Brookes, Jia Rong Pang, Alexandre Urani, Philip R. Holland and Jan Hoffmann
    Citation: The Journal of Headache and Pain 2023 24:123
  10. Migraine is a highly prevalent primary headache disorder and a leading cause of disability. Difficulties in access to care during diagnostic and therapeutic journey contribute to the disease burden. Several ta...

    Authors: Gloria Vaghi, Roberto De Icco, Cristina Tassorelli, Peter J. Goadsby, Teófila Vicente-Herrero and Elena Ruiz de la Torre
    Citation: The Journal of Headache and Pain 2023 24:120
  11. Headache disorders are widely prevalent and pose a considerable economic burden on individuals and society. Globally, misdiagnosis and inadequate treatment of primary headache disorders remain significant chal...

    Authors: Huanxian Liu, Ming Dong, Kaiming Liu, Zhihua Jia, Wei Gui, Yingying Cheng, Yudan Lv, Kang Qu, Hongru Zhao, Jianjun Chen, Dan Zhang, Zhiliang Fan, Xiaosu Yang, Dongmei Hu, Hongyan Xie, Mingxin Li…
    Citation: The Journal of Headache and Pain 2023 24:119
  12. Data are limited regarding the combined impact of headache frequency and failure of preventive medication (efficacy and/or tolerability) on the humanistic/economic burden of migraine.

    Authors: Dawn C. Buse, Patricia Pozo-Rosich, Laure Dupont-Benjamin, Bridget L. Balkaran, Lulu Lee, Adam Jauregui, Pranav Gandhi, Mousam Parikh and Uwe Reuter
    Citation: The Journal of Headache and Pain 2023 24:115
  13. Primary headache disorders are a group of highly prevalent and disabling neurological diseases that mainly consist of migraine and tension-type headache (TTH). A previous study showed that the burden of headac...

    Authors: Rongguang Ge, Jie Chang and Yongjun Cao
    Citation: The Journal of Headache and Pain 2023 24:110
  14. Migraine is a very common headache disorder on the population level, characterized by symptomatic attacks (activity). For many people with migraine, the migraine symptoms intermittently or permanently cease du...

    Authors: Marco Piccininni, Ralph Brinks, Jessica L. Rohmann and Tobias Kurth
    Citation: The Journal of Headache and Pain 2023 24:83
  15. The close relationship between pain and mental health problems is well-known, and psychological intervention can provide an effective alternative to medication-based pain relief. However, previous studies on t...

    Authors: Chongjie Yao, Yuchen Zhang, Ping Lu, Bin Xiao, Pingping Sun, Jiming Tao, Yanbin Cheng, Lingjun Kong, Dongsheng Xu and Min Fang
    Citation: The Journal of Headache and Pain 2023 24:82
  16. The majority of epidemiological studies on migraine have been conducted in a specific country or region, and there is a lack of globally comparable data. We aim to report the latest information on global migra...

    Authors: Luying Fan, Yuhang Wu, Jiehua Wei, Fan Xia, Yufeng Cai, Senmao Zhang, Junxiang Miao, Yunzhe Zhou, Chu Liu, Wei Yan, Dan Liu, Lizhang Chen and Tingting Wang
    Citation: The Journal of Headache and Pain 2023 24:79
  17. Although headache disorders are common, the current diagnostic approach is unsatisfactory. Previously, we designed a guideline-based clinical decision support system (CDSS 1.0) for diagnosing headache disorder...

    Authors: Xun Han, Dongjun Wan, Shuhua Zhang, Ziming Yin, Siyang Huang, Fengbo Xie, Junhong Guo, Hongli Qu, Yuanrong Yao, Huifang Xu, Dongfang Li, Sufen Chen, Faming Wang, Hebo Wang, Chunfu Chen, Qiu He…
    Citation: The Journal of Headache and Pain 2023 24:57
  18. Although studies have identified a high prevalence of migraine among employees in the banking sector, the symptoms of migraine, related disability and occupational risk factors are not well understood.

    Authors: Du Wei, Tharani Loganathan and Li Ping Wong
    Citation: The Journal of Headache and Pain 2023 24:52
  19. Headaches are frequent neurological disorders that are yet to be unveiled and treated comprehensively worldwide. Bearing in mind that the distribution of headache subtypes in neurology clinics (NC) is essentia...

    Authors: H. Genc, B. Baykan, H. Bolay, D. Uluduz, I. Unal-Cevik, N. Kissani, O. Luvsannorov, M. Togha, A. A. Ozdemir and A. Ozge
    Citation: The Journal of Headache and Pain 2023 24:24

Submission Guidelines

Back to top

This Collection welcomes several different types of journal manuscripts, e.g., research articles, consensus articles, reviews, and commentaries. Before submitting your manuscript, please ensure you have read our submission guidelines. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select One Health for Headache from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer-review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.